Artificial Intelligence in Drug Discovery Market Share

AI in Drug Discovery Market Share

Prominent players involved in the market include IBM Corporation, NVIDIA Corporation, Microsoft Corporation, Exscientia and several other local and regional players. These industry players are constantly involved in creating new opportunities in the drug discovery sector. They focus on strategic collaborations, acquisitions, partnerships, mergers, service launches, etc. to maintain their position in the market and secure the highest market share and outperform the competition.
 

For instance, in February 2023, Microsoft and 1910 Genetics, a biotechnology company advancing small and large molecule drug discovery with a multimodal AI platform, announced a new five-year commercial agreement and go-to-market collaboration to harness advanced AI and next generation high-performance computing (HPC). The collaboration aimed to increase the R&D productivity by combining 1910’s massive computational and wet lab biological data, robotics-driven laboratory automation and multimodal AI models for drug discovery with Microsoft Azure Quantum Elements. Such strategies help the market players maintain their position in the market.
 

AI in Drug Discovery Market Companies

Key players operating in the artificial intelligence in drug discovery industry include:

• Alphabet Inc. (DeepMind)
• Atomwise Inc.
• BenevolentAI
• Cyclica
• Deep Genomic
• Deargen Inc.
• Exscientia
• International Business Machines Corporation
• Microsoft Corporation
• NVIDIA Corporation